Funder
Israel Science Foundation
TAU | Varda and Boaz Dotan Research Center for Hemato-Oncology Research, Tel Aviv University
Canadian Cancer Society Research Institute
Council of Scientific and Industrial Research
Department of Biotechnology, Ministry of Science and Technology
DST | Science and Engineering Research Board
Indian Council of Medical Research
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference62 articles.
1. Tran N, Broun A, Ge K. Lysine demethylase KDM6A in differentiation, development, and cancer. Mol Cell Biol. 2020;40:e00341–20.
2. Yu SH, Zhu KY, Chen J, Liu XZ, Xu PF, Zhang W, et al. JMJD3 facilitates C/EBPbeta-centered transcriptional program to exert oncorepressor activity in AML. Nat Commun. 2018;9:3369.
3. Ohguchi H, Harada T, Sagawa M, Kikuchi S, Tai YT, Richardson PG, et al. KDM6B modulates MAPK pathway mediating multiple myeloma cell growth and survival. Leukemia. 2017;31:2661–9.
4. Boila LD, Chatterjee SS, Banerjee D, Sengupta A. KDM6 and KDM4 histone lysine demethylases emerge as molecular therapeutic targets in human acute myeloid leukemia. Exp Hematol. 2018;58:44–51.e7.
5. Lan F, Bayliss PE, Rinn JL, Whetstine JR, Wang JK, Chen S, et al. A histone H3 lysine 27 demethylase regulates animal posterior development. Nature. 2007;449:689–94.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献